Last reviewed · How we verify
Polyethylene Glycol Recombinant Human Somatropin
Polyethylene Glycol Recombinant Human Somatropin is a Small molecule drug developed by Shandong University. It is currently in Phase 1 development.
At a glance
| Generic name | Polyethylene Glycol Recombinant Human Somatropin |
|---|---|
| Sponsor | Shandong University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics (PHASE2)
- The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
- A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature (PHASE2)
- A Bioequivalence Study of Two Different PEG-rhGH Preparations (PHASE1)
- A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations (PHASE1)
- A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations (PHASE1)
- A Bioavailability Study of Two Different PEG-rhGH Preparations. (PHASE1)
- PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Polyethylene Glycol Recombinant Human Somatropin CI brief — competitive landscape report
- Polyethylene Glycol Recombinant Human Somatropin updates RSS · CI watch RSS
- Shandong University portfolio CI
Frequently asked questions about Polyethylene Glycol Recombinant Human Somatropin
What is Polyethylene Glycol Recombinant Human Somatropin?
Polyethylene Glycol Recombinant Human Somatropin is a Small molecule drug developed by Shandong University.
Who makes Polyethylene Glycol Recombinant Human Somatropin?
Polyethylene Glycol Recombinant Human Somatropin is developed by Shandong University (see full Shandong University pipeline at /company/shandong-university).
What development phase is Polyethylene Glycol Recombinant Human Somatropin in?
Polyethylene Glycol Recombinant Human Somatropin is in Phase 1.